查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球宏基因組市場：按應用、技術、產品和使用者進行預測 - 附執行顧問指南（2024-2028）
市場調查報告書
商品編碼
1430100

全球宏基因組市場：按應用、技術、產品和使用者進行預測 - 附執行顧問指南（2024-2028）

Metagenomic Markets. Global Market Analysis with Forecasts by Applications, Technologies, Product and User. With Executive and Consultant Guides. 2024 to 2028
出版日期: | 出版商: Howe Sound Research | 英文 359 Pages | 商品交期: 最快1-2個工作天內

價格

遺傳學在健康和疾病中的作用直到現在才被人們了解。 這些新知識加上成本的下降，正在催生新型基因檢測。 宏基因組測試檢查樣本中的所有遺傳物質。 在這個過程中，我們可以了解傳染病、癌症、抗菌素抗藥性和患者基因組，這是一種全新的方法。 從人類醫學到廢水研究，這種新方法正在產生令人驚訝的答案。 在此過程中，我們正在發現新類型的生物體和病原體。 一些小小的醫學奇蹟已經實現。

本報告審視了全球基因檢測市場，並提供了市場概述、應用、技術、產品和用戶的趨勢，以及進入市場的公司概況。

目錄

第一章市場指南

第 2 章介紹與市場定義

第三章市場概述

  • 市場准入組織
    • 學術研究所
    • 診斷測試開發人員
    • 儀器供應商
    • 藥品/試劑製造商
    • 病理供應商
    • 獨立的臨床實驗室
    • 公共國家/地區研究機構
    • 醫院實驗室
    • 臨床實驗室
    • 審計機構
    • 認證機構
  • 宏基因體學的應用
    • 臨床宏基因體學
    • 診斷用途
    • 多種症候群檢測和宏基因組檢測
    • 抗菌素抗藥性
    • 微生物組管理
    • 公共衛生用途
  • 臨床行業結構

第四章市場趨勢

  • 生長促進因素
  • 抑制生長的因素
  • 測量、自動化和診斷的趨勢

第五章宏基因體學的最新進展

第六章主要公司概況

  • Arc Bio
  • BaseClear
  • BGI Genomics Co. Ltd.
  • Biome Makers
  • bioMérieux Diagnostics
  • Bio-Rad Laboratories, Inc.
  • CosmosID
  • Element Biosciences
  • Fusion Genomics.
  • Helix OpCo
  • Illumina
  • Institute for Metagenomics
  • Karius
  • Metabiomics Corp.
  • Metagenomi
  • MetaSUB International Consortium
  • Microbiome Insights
  • MicroGenDx
  • Molecular Stethoscope
  • Norgen Biotek Corp.
  • Noscendo
  • Novogene Bioinformatics Technology Co., Ltd.
  • One Codex
  • OraSure Technologies
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • PathoQuest S.A.
  • Perkin Elmer
  • Promega
  • Qiagen
  • Second Genome
  • Siemens Healthineers
  • Sysmex
  • Takara Bio
  • Ultima Genomics
  • Zymo Research Corp.

第七章世界市場規模

  • 按國家/地區劃分的世界市場
  • 按應用劃分的世界市場
  • 依科技劃分的世界市場
  • 按產品劃分的世界市場
  • 按使用者劃分的世界市場

第 8 章按應用劃分的市場規模

  • 臨床市場
  • 微生物組市場
  • 農產品市場
  • 工業及其他

第 9 章依科技劃分的市場規模

  • 16srRNA市場
  • 霰彈槍市場
  • WGS 市場
  • 其他

第 10 章依產品劃分的市場規模

  • 設備市場
  • 試劑/試劑盒市場
  • 軟體市場
  • 服務市場

第 11 章用戶市場規模

  • 學術市場
  • 臨床市場
  • 醫藥市場
  • 其他

第12章附錄

OVERVIEW:

Unlimited growth potential? A Game Changer? It is not exaggeration. Metagenomic assays could change the way medical treatment is done. Learn all about it in this new research report.

The role of genetics in health and disease is just now being understood. This new knowledge, combined with lower costs is driving a new type of genetic testing. Metagenomic Testing looks at all the genetic material in a sample. In the process it learns about infection, cancer, antimicrobial resistance, and the patient genome. It's a whole new approach. Chronic infection? Find out the real culprits. Secrets of the microbiome and gut health? Metagenomics has the answers. In everything from human medical treatment to wastewater studies this new approach is creating startling answers. And finding new kinds of organisms and pathogens in the process. Already some minor medical miracles have been accomplished. This report looks at the technology, the applications, the users and the types of products that will be sold. The report includes detailed breakouts for 14 countries and 5 regions.

Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1. Market Guides

  • 1.1. Strategic Situation Analysis
  • 1.2. Guide for Executives and Business Development Staff
  • 1.3. Guide for Management Consultants and Investment Advisors

2. Introduction and Market Definition

  • 2.1. What is Metagenomics?
  • 2.2. Market Definition
    • 2.2.1. Revenue Market Size.
    • 2.2.2. Clinical
    • 2.2.3. Microbiome
    • 2.2.4. Agricultural
    • 2.2.5. Environmental & Other
  • 2.3. Methodology
    • 2.3.1. Methodology
    • 2.3.2. Sources
    • 2.3.3. Authors
  • 2.4. Perspective: Healthcare and the IVD Industry
    • 2.4.1. Global Healthcare Spending
    • 2.4.2. Spending on Diagnostics
    • 2.4.3. Important Role of Insurance for Diagnostics
  • 2.5. Chromosomes, Genes and Epigenetics
    • 2.5.1. Chromosomes
    • 2.5.2. Genes
    • 2.5.3. Epigenetics

3. Market Overview

  • 3.1. Players in a Dynamic Market
    • 3.1.1. Academic Research Lab
    • 3.1.2. Diagnostic Test Developer
    • 3.1.3. Instrumentation Supplier
    • 3.1.4. Chemical/Reagent Supplier
    • 3.1.5. Pathology Supplier
    • 3.1.6. Independent Clinical Laboratory
    • 3.1.7. Public National/regional Laboratory
    • 3.1.8. Hospital Laboratory
    • 3.1.9. Physicians Office Lab (POLS)
    • 3.1.10. Audit Body
    • 3.1.11. Certification Body
  • 3.2. Metagenomics Applications
    • 3.2.1. Clinical Metagenomics
    • 3.2.2. Diagnostic Use
    • 3.2.3. Syndromic Multiplex vs. Metagenomic Testing
    • 3.2.4. Antimicrobial Resistance
    • 3.2.5. Managing the Microbiome
    • 3.2.6. Public Health Use
  • 3.3. Clinical Industry Structure
    • 3.3.1. Hospital's Testing Share
    • 3.3.2. Economies of Scale
    • 3.3.3. Hospital vs. Central Lab
    • 3.3.4. Physician Office Lab's
    • 3.3.5. Physician's and POCT

4. Market Trends

  • 4.1. Factors Driving Growth
    • 4.1.1. A New Approach to Diagnostics
    • 4.1.2. The Aging Effect
    • 4.1.3. The Known and the Unknown
    • 4.1.4. A Research Bonanza
  • 4.2. Factors Limiting Growth
    • 4.2.1. Increased Competition Lowers Price
    • 4.2.2. Lower Costs
    • 4.2.3. Testing usage analysis curtailing growth
    • 4.2.4. Wellness has a downside
  • 4.3. Instrumentation, Automation and Diagnostic Trends
    • 4.3.1. Traditional Automation and Centralization
    • 4.3.2. The New Automation, Decentralization and Point of Care
    • 4.3.3. Instruments Key to Market Share
    • 4.3.4. Bioinformatics Plays a Role
    • 4.3.5. PCR Takes Command
    • 4.3.6. Next Generation Sequencing Fuels a Revolution
    • 4.3.7. NGS Impact on Pricing
    • 4.3.8. Whole Genome Sequencing, A Brave New World
    • 4.3.9. Companion Diagnostics Blurs Diagnosis and Treatment
    • 4.3.10. Shifting Role of Diagnostics

5. Metagenomics Recent Developments

  • 5.1. Recent Developments
    • 5.1.1. Importance of This Section
    • 5.1.2. How to Use This Section
  • 5.2. UK and U.S. Use Metagenomics for Biothreat Assessment
  • 5.3. Phase Genomics Metagenomics Innovation Award
  • 5.4. New Method for Human Gut Assessment
  • 5.5. Metagenomic sequencing Used for Pneumonia Care
  • 5.6. Sepsis Study Shows Metagenomic Clinical Value
  • 5.7. Delve Bio to Develop Metagenomic Sequencing Dx
  • 5.8. Metagenomics Could be a Game-changer
  • 5.9. Model Predicts Millions of Metagenomic Proteins
  • 5.10. Microbiome Analysis May Yield False Results
  • 5.11. Gut microbiome at center of Parkinson's disease
  • 5.12. MicroGenDx, Evvy Partner for Metagenomic Test
  • 5.13. Diagnostic accuracy of metagenomic NGS
  • 5.14. Metagenomics implicates the gut microbiome
  • 5.15. Charities Award $2M for Metagenomic Pathogen Research
  • 5.16. Cost-effective metagenomic HiFi sequencing
  • 5.17. Microbiome Links Uncovered
  • 5.18. Metagenomi Named an Endpoints 11 Winner
  • 5.19. Biotia Raises $8M in Series A Financing

6. Profiles of Key Companies

  • 6.1. Arc Bio
  • 6.2. BaseClear
  • 6.3. BGI Genomics Co. Ltd.
  • 6.4. Biome Makers
  • 6.5. bioMérieux Diagnostics
  • 6.6. Bio-Rad Laboratories, Inc.
  • 6.7. CosmosID
  • 6.8. Element Biosciences
  • 6.9. Fusion Genomics.
  • 6.10. Helix OpCo
  • 6.11. Illumina
  • 6.12. Institute for Metagenomics
  • 6.13. Karius
  • 6.14. Metabiomics Corp.
  • 6.15. Metagenomi
  • 6.16. MetaSUB International Consortium
  • 6.17. Microbiome Insights
  • 6.18. MicroGenDx
  • 6.19. Molecular Stethoscope
  • 6.20. Norgen Biotek Corp.
  • 6.21. Noscendo
  • 6.22. Novogene Bioinformatics Technology Co., Ltd.
  • 6.23. One Codex
  • 6.24. OraSure Technologies
  • 6.25. Oxford Nanopore Technologies
  • 6.26. Pacific Biosciences
  • 6.27. PathoQuest S.A.
  • 6.28. Perkin Elmer
  • 6.29. Promega
  • 6.30. Qiagen
  • 6.31. Second Genome
  • 6.32. Siemens Healthineers
  • 6.33. Sysmex
  • 6.34. Takara Bio
  • 6.35. Ultima Genomics
  • 6.36. Zymo Research Corp.

7. Global Market Size

  • 7.1. Global Market by Country
    • 7.1.1. Table - Global Market by Country
    • 7.1.2. Chart - Country Market Shares
  • 7.2. Global Market by Application
    • 7.2.1. Table - Global Market by Application
    • 7.2.2. Chart - Application Share by Year
    • 7.2.3. Chart - Application Segment Growth Rates
    • 7.2.4. Chart - Application Segment Share Shifts
    • 7.2.5. Chart - Application Segment Share Base Year
    • 7.2.6. Chart - Application Segment Share Final Year
  • 7.3. Global Market by Technology
    • 7.3.1. Table - Global Market by Technology
    • 7.3.2. Chart - Technology Share by Year
    • 7.3.3. Chart - Technology Segment Growth Rates
    • 7.3.4. Chart - Technology Segment Share Shifts
    • 7.3.5. Chart - Technology Segment Share Base Year
    • 7.3.6. Chart - Technology Segment Share Final Year
  • 7.4. Global Market by Product
    • 7.4.1. Table - Global Market by Product
    • 7.4.2. Chart - Product Share by Year
    • 7.4.3. Chart - Product Segment Growth Rates
    • 7.4.4. Chart - Product Segment Share Shifts
    • 7.4.5. Chart - Product Segment Share Base Year
    • 7.4.6. Chart - Product Segment Share Final Year
  • 7.5. Global Market by User
    • 7.5.1. Table - Global Market by User
    • 7.5.2. Chart - User Share by Year
    • 7.5.3. Chart - User Segment Growth Rates
    • 7.5.4. Chart - User Segment Share Shifts
    • 7.5.5. Chart - User Segment Share Base Year
    • 7.5.6. Chart - User Segment Share Final Year

8. Market Sizes by Application

  • 8.1. Clinical Market
    • 8.1.1. Table Clinical - by Country
    • 8.1.2. Chart - Clinical Growth
  • 8.2. Microbiome Market
    • 8.2.1. Table Microbiome - by Country
    • 8.2.2. Chart - Microbiome Growth
  • 8.3. Agriculture Market
    • 8.3.1. Table Agriculture - by Country
    • 8.3.2. Chart - Agriculture Growth
  • 8.4. Industrial & Other Market
    • 8.4.1. Table Industrial & Other - by Country
    • 8.4.2. Chart - Industrial & Other Growth

9. Market Sizes by Technology

  • 9.1. 16srRNA Market
    • 9.1.1. Table 16srRNA - by Country
    • 9.1.2. Chart - 16srRNA Growth
  • 9.2. Shotgun Market
    • 9.2.1. Table Shotgun - by Country
    • 9.2.2. Chart - Shotgun Growth
  • 9.3. WGS Market
    • 9.3.1. Table WGS - by Country
    • 9.3.2. WGS - Growth
  • 9.4. Other Technology Market
    • 9.4.1. Table Other Technology - by Country
    • 9.4.2. Chart - Other Technology Growth

10. Market Sizes by Product

  • 10.1. Instruments Market
    • 10.1.1. Table Instruments - by Country
    • 10.1.2. Chart - Instrument Growth
  • 10.2. Reagents and Kits Market
    • 10.2.1. Table Reagents and Kits - by Country
    • 10.2.2. Chart - Reagents and Kits Growth
  • 10.3. Software Market
    • 10.3.1. Table Software - by Country
    • 10.3.2. Software Growth
  • 10.4. Services Market
    • 10.4.1. Table Services - by Country
    • 10.4.2. Chart - Services Growth

11. Market Sizes by User

  • 11.1. Academic Market
    • 11.1.1. Table Academic - by Country
    • 11.1.2. Chart - Academic Growth
  • 11.2. Clinical Market
    • 11.2.1. Table Clinical - by Country
    • 11.2.2. Chart - Clinical Growth
  • 11.3. Pharmaceutical Market
    • 11.3.1. Table Pharmaceutical - by Country
    • 11.3.2. Pharmaceutical - Predictive Growth
  • 11.4. Other User Market
    • 11.4.1. Table Other User - by Country
    • 11.4.2. Chart - Other User Growth

12. Appendices

  • 12.1. United States Medicare System: Laboratory Fees Schedule
  • 12.2. The Most Used IVD Assays
  • 12.3. The Highest Grossing Assays

Table of Tables

  • Table 1: The Base Pairs
  • Table 2: Market Players by Type
  • Table 3: The Different Applications of Metagenomic Testing
  • Table 4: Factors Driving Growth
  • Table 5: Four Factors Limiting Growth
  • Table 6: Seven Key Diagnostic Laboratory Technology Trends
  • Table 7: Global Market by Country
  • Table 8: Global Market by Application
  • Table 9: Global Market by Technology
  • Table 10: Global Market by Product
  • Table 11: Global Market by User
  • Table 12: Clinical Segment by Country
  • Table 13: Microbiome Segment by Country
  • Table 14: Agriculture Segment by Country
  • Table 15: Industrial & Other Segment by Country
  • Table 16: 16srRNA Segment by Country
  • Table 17: Shotgun Segment by Country
  • Table 18: WGS Segment by Country
  • Table 19: Other Technology Segment by Country
  • Table 20: Instruments Segment by Country
  • Table 21: Reagents and Kits Segment by Country
  • Table 22: Software Segment by Country
  • Table 23: Services Segment by Country
  • Table 24: Academic Segment by Country
  • Table 25: Clinical Segment by Country
  • Table 26: Pharmaceutical Segment by Country
  • Table 27: Other User Segment by Country
  • Table 28: Clinical Lab Fee Schedule
  • Table 29: The Most Common Assays
  • Table 30: Largest Revenue Assays

Table of Figures

  • Figure 1: Global Health Care Spending
  • Figure 2: The Lab Test Pie
  • Figure 3: DNA Strands and Chromosomes
  • Figure 4: Karyogram of Human Chromosomes
  • Figure 5: Size of Various Genomes
  • Figure 6: The Road to Diagnostics
  • Figure 7: The New Diagnostics
  • Figure 8: The Changing Age of the World Population
  • Figure 9: Health Care Consumption by Age
  • Figure 10: Cancer Incidence - Age at Diagnosis
  • Figure 11: Centralized vs. Decentralized Laboratory Service
  • Figure 12: A Highly Multiplexed Syndromic Testing Unit
  • Figure 13: The Real Cost to Sequence the Human Genome
  • Figure 14: The Codevelopment Process
  • Figure 15: Comparing MDx Diagnostic and Traditional Testing
  • Figure 16: Country Market Shares
  • Figure 17: Application Share by Year
  • Figure 18: Application Segment Growth Rates
  • Figure 19: Segment Share Shifts
  • Figure 20: Application Segment Share Base Year
  • Figure 21: Application Segment Share Final Year
  • Figure 22: Technology Share by Year
  • Figure 23: Technology Segment Growth Rates
  • Figure 24: Technology Segment Share Shifts
  • Figure 25: Technology Segment Share Base Year
  • Figure 26: Technology Segment Share Final Year
  • Figure 27: Product Share by Year
  • Figure 28: Product Segment Growth Rates
  • Figure 29: Product Segment Share Shifts
  • Figure 30: Product Segment Share Base Year
  • Figure 31: Product Segment Share Final Year
  • Figure 32: User Share by Year
  • Figure 33: User Segment Growth Rates
  • Figure 34: User Segment Share Shifts
  • Figure 35: User Segment Share Base Year
  • Figure 36: User Segment Share Final Year
  • Figure 37: Clinical vs. Total Market Growth
  • Figure 38: Microbiome vs. Total Market Growth
  • Figure 39: Agriculture vs. Total Market Growth
  • Figure 40: Industrial & Other vs. Total Market Growth
  • Figure 41: 16srRNA vs. Total Market Growth
  • Figure 42: Shotgun vs. Total Market Growth
  • Figure 43: WGS vs. Total Market Growth
  • Figure 44: Other Technology vs. Total Market Growth
  • Figure 45: Instrument vs. Total Market Growth
  • Figure 46: Reagents and Kits vs. Total Market Growth
  • Figure 47: Software vs. Total Market Growth
  • Figure 48: Services vs. Total Market Growth
  • Figure 49: Academic vs. Total Market Growth
  • Figure 50: Clinical vs. Total Market Growth
  • Figure 51: Pharmaceutical vs. Total Market Growth
  • Figure 52: Other User Growth